Skip to menu Skip to content Skip to footer

2006

Journal Article

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing

Farshid, G, Balleine, RL, Cummings, M, Waring, P and kConFab Grp (2006). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. American Journal of Surgical Pathology, 30 (11), 1357-1366. doi: 10.1097/01.pas.0000213273.22844.1a

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing

2006

Journal Article

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

Bilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 (2), 120-124. doi: 10.1080/00313020600561518

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

2005

Journal Article

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma

Arnold, J. M., Huggard, P. R., Cummings, M., Ramm, G. A. and Chenevix-Trench, G. (2005). Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. British Journal of Cancer, 92 (11), 2024-2031. doi: 10.1038/sj.bjc.6602596

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma

2004

Journal Article

Changes in survival after breast cancer: improvements in diagnosis or treatment?

Webb, PM, Cummings, MC, Bain, CJ and Furnival, CM (2004). Changes in survival after breast cancer: improvements in diagnosis or treatment?. Breast, 13 (1), 7-14. doi: 10.1016/S0960-9776(03)00129-2

Changes in survival after breast cancer: improvements in diagnosis or treatment?

2003

Journal Article

Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status

Michael-Robinson, Julie M., Pandeya, Nirmala, Cummings, Margaret C., Walsh, Michael D., Young, Joanne P., Leggett, Barbara A., Purdie, David M., Jass, Jeremy R. and Radford-Smith, Graham L. (2003). Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. Journal of Pathology, 201 (1), 46-54. doi: 10.1002/path.1406

Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status

2003

Journal Article

Occult metastases in breast cancer

Cummings, M. C. (2003). Occult metastases in breast cancer. Cancer Forum, 27 (2), 95-97.

Occult metastases in breast cancer

2003

Journal Article

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

Bilous, M., Ades, C., Armes, J., Bishop, J., Brown, R., Cooke, B., Cummings, M., Farshid, G., Field, A., Morey, A., McKenzie, P., Raymond, W., Robbins, P. and Tan, L. (2003). Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast, 12 (2), 92-98. doi: 10.1016/S0960-9776(02)00273-4

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

2002

Journal Article

Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis

Cummings, M. C., Walsh, M. D., Hohn, B. G, Bennett, I. C., Wright, R. G. and McGuckin, M. A. (2002). Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. American Journal of Surgical Pathology, 26 (10), 1286-1295. doi: 10.1097/00000478-200210000-00005

Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis

2002

Journal Article

Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma

Whiteman, David C., Zhou, Xiao-Ping, Cummings, Margaret C., Pavey, Sandra, Hayward, Nicholas K. and Eng, Charis (2002). Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. International Journal of Cancer, 99 (1), 63-67. doi: 10.1002/ijc.10294

Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma

2002

Journal Article

Dominant negative ATM mutations in breast cancer families

Chenevix-Trench, Georgia, Spurdle, Amanda B., Gatei, Magtouf, Kelly, Helena, Marsh, Anna, Chen, Xiaoqing, Donn, Karen, Cummings, Margaret C., Nyholt, Dale, Jenkins, Mark A., Scott, Clare, Pupo, Gulietta M., Dork, Thilo, Bendix, Regina, Kirk, Judy, Tucker, Katherine, McCredie, Margaret R. E., Hopper, John L., Sambrook, Joseph, Mann, Graham J. and Khanna, Kum Kum (2002). Dominant negative ATM mutations in breast cancer families. Journal of the National Cancer Institute, 94 (3), 205-215. doi: 10.1093/jnci/94.3.205

Dominant negative ATM mutations in breast cancer families

2002

Journal Article

Loss of p16 expression is associated with histological features of melanoma invasion

Pavey, S. J., Cummings, M. C., Whiteman, D. C., Castellano, M., Walsh, M. D., Gabrielli, B. G., Green, A. and Hayward, N. K. (2002). Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Research, 12 (6), 539-547. doi: 10.1097/01.cmr.0000043154.28051.9f

Loss of p16 expression is associated with histological features of melanoma invasion

2001

Journal Article

HER2 testing recommendations in Australia

Bilous, Michael, Ades, Colin, Armes, Jane, Bell, Richard, Brown, Robert, Cook, Bridget, Cummings, Margaret C., Field, Andrew, Llewellyn, Huw, McKenzie, Paul, Raymond, Wendy, Robbins, Peter and Tan, Lisa (2001). HER2 testing recommendations in Australia. Pathology, 33 (4), 425-427. doi: 10.1080/00313020120083133

HER2 testing recommendations in Australia

2001

Journal Article

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

Arnold, J. M., Cummings, M., Purdie, D. and Chenevix-Trench, G. (2001). Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. British Journal of Cancer, 85 (9), 1351-1358. doi: 10.1054/bjoc.2001.2075

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

2000

Journal Article

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., Wells, C. A., Little, M. H., Cummings, M. C., Hayward, N. K. and Kay, G. F. (2000). Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circulation Research, 86 (2), E29-E35.

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

2000

Journal Article

Expression of p53 in arsenic-related and sporadic basal cell carcinoma

Boonchai, Waranya, Walsh, Michael, Cummings, Margaret and Chenevix-Trench, Georgia (2000). Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Archives of Dermatology, 136 (2), 195-198. doi: 10.1001/archderm.136.2.195

Expression of p53 in arsenic-related and sporadic basal cell carcinoma

2000

Journal Article

Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma

Aubele, M., Cummings, M. C., Walch, A. K., Zitzelsberger, H., Nahrig, J., Hofler, H. and Werner, M. (2000). Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Analytical Cellular Pathology, 20 (1), 17-24. doi: 10.1155/2000/930246

Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma

2000

Journal Article

Expression of b-catenin, a key mediator of the wnt signaling pathway, in basal cell carcinoma

Boonchai, W., Walsh, M., Cummings, M. C. and Chenevix-Trench, G. (2000). Expression of b-catenin, a key mediator of the wnt signaling pathway, in basal cell carcinoma. Archives of Dermatology, 136 (7), 937-938. doi: 10.1001/archderm.136.7.937

Expression of b-catenin, a key mediator of the wnt signaling pathway, in basal cell carcinoma

2000

Journal Article

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer

Aubele, M. M., Cummings, M. C., Mattis, A. E., Zitzelsberger, H. F., Walch, A. K., Kremer, M., Hofler, H. and Werner, M (2000). Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagnostic Molecular Pathology, 9 (1), 14-19. doi: 10.1097/00019606-200003000-00003

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer

2000

Journal Article

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis

Cummings, M. C., Aubele, M., Mattis, A., Purdie, D., Hutzler, P., Hofler, H. and Werner, M. (2000). Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis. British Journal of Cancer, 82 (6), 1204-1210. doi: 10.1054/bjoc.1999.1064

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis

1999

Journal Article

20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.

Werner, M., Mattis, A., Aubele, M., Cummings, M. C., Zitzelsberger, H., Hutzler, P. and Hofler, H. (1999). 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.. Virchows Archiv, 435 (5), 469-472. doi: 10.1007/s004280050429

20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.